Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
FP01 - Early Stage/Localized Disease/Ablative Therapies
- Type: Posters (Featured)
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP01.01 - The Association of Bevacizumab with a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505 in Completely Resected Stage IB-IIIA NSCLC
00:00 - 00:00 | Presenter: John Varlotto
- Abstract
Loading...
-
+
FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies
- Type: Posters (Featured)
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
00:00 - 00:00 | Author(s): Patrick Forde
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP08 - Multimodality Management of Advanced Lung Cancer
- Type: Posters (Featured)
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP08.01 - Lung Stereotactic Body Radiation Therapy for Treatment of Oligoprogressive and Oligorecurrent Metastatic Disease: A Multi-Center Analysis
00:00 - 00:00 | Presenter: Sibo Tian
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP09 - Novel Therapeutics and Targeted Therapies
- Type: Posters (Featured)
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP09.01 - Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy
00:00 - 00:00 | Presenter: Pasi A. Janne
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP09.02 - Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort
00:00 - 00:00 | Presenter: Maria Rosario García Campelo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP16 - Tumor Biology and Systems Biology: Basic and Translational Science
- Type: Posters (Featured)
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP16.03 - Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial
00:00 - 00:00 | Presenter: Myung-Ju Ahn
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 8
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P50.05 - Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
00:00 - 00:00 | Presenter: Madhusmita Behera
- Abstract
Loading...
-
+
P52 - Novel Therapeutics and Targeted Therapies - KRAS
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P52.03 - Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100
00:00 - 00:00 | Presenter: Suresh Ramalingam
- Abstract
Loading...
-
+
P53 - Novel Therapeutics and Targeted Therapies - Others
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 8
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P53.08 - Concomitant Fibrates and Immunotherapy in Non-Small Cell Lung Cancer Patients in the Veterans Health Administration
00:00 - 00:00 | Presenter: William A Stokes
- Abstract
Loading...
-
+
MA01 - Multimodality Management of Advanced Lung Cancer
- Type: Mini Oral
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 8
- Coordinates: 9/08/2021, 08:15 - 09:15, Program Auditorium
-
+
MA01.06 - Effects of the Immunotherapy Era on Maintenance Outcomes in Advanced Nonsquamous NSCLC: Subgroup Analysis of ECOG 5508
08:50 - 08:55 | Presenter: Bharathi Muthusamy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA01 - The Impact of COVID-19 on Patients with Lung Cancer
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 5
- Moderators:Enriqueta Felip
- Coordinates: 9/08/2021, 08:15 - 09:15, Program Auditorium
-
+
OA01.04 - Discussant
08:45 - 08:55 | Presenter: Suresh Ramalingam
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
